Strategic partnerships Explore co-development and financing opportunities with Click Therapeutics leveraging their Series D funding and existing pharmaceutical collaborations (eg Boehringer) to co-market FDA-approved digital therapeutics for schizophrenia and other indications.

Expansion & commercialization Target opportunities tied to Click’s efforts to commercialize CT-155 and other platform therapies, aligning with payers and health systems to accelerate adoption of prescription digital therapeutics in psychiatry, neurology, oncology, cardiology, and immunology.

Migraine ecosystem Leverage Click’s Migraine PowerPlug collaborations with Ultrahuman to offer integrated digital-physical health solutions, presenting a joint value proposition to wearable and health-tech partners and migraine care pathways.

Clinical rigor & AI Position services around Click’s data-driven platform, AI/ML capabilities, and FDA-regulated digital therapeutics to support sponsor trials, real-world evidence generation, and scalable deployment for diverse therapeutic areas.

Workforce & sustainability Offer capabilities to support Click’s growth while addressing recent headcount adjustments; propose scalable external development and services partnerships to sustain innovation, regulatory compliance, and timely product launches.